| Primary |
| Crohn's Disease |
62.5% |
| Autoimmune Thyroiditis |
6.3% |
| Bronchiectasis |
6.3% |
| Chronic Obstructive Pulmonary Disease |
6.3% |
| Colitis |
6.3% |
| Essential Hypertension |
6.3% |
| Gastritis |
6.3% |
|
| White Blood Cell Count Decreased |
22.2% |
| Hepatosplenic T-cell Lymphoma |
11.1% |
| Pancreatitis |
11.1% |
| Pancreatitis Acute |
11.1% |
| Product Substitution Issue |
11.1% |
| Therapeutic Response Unexpected With Drug Substitution |
11.1% |
| Tuberculosis |
11.1% |
| Vomiting |
11.1% |
|
| Secondary |
| Acute Lymphocytic Leukaemia |
18.1% |
| Colitis Ulcerative |
14.7% |
| Crohn's Disease |
11.8% |
| Inflammatory Bowel Disease |
8.8% |
| Acute Myeloid Leukaemia |
6.3% |
| Haematological Malignancy |
5.4% |
| Bronchopulmonary Aspergillosis |
5.3% |
| Product Used For Unknown Indication |
5.3% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
4.8% |
| Drug Use For Unknown Indication |
4.2% |
| Irritable Bowel Syndrome |
2.9% |
| Leukaemia |
2.7% |
| Angioimmunoblastic T-cell Lymphoma |
2.0% |
| Osteoporosis |
1.4% |
| Acute Promyelocytic Leukaemia |
1.3% |
| Acne |
1.1% |
| Caecitis |
1.1% |
| Hodgkin's Disease |
1.0% |
| Prophylaxis |
1.0% |
| Pyrexia |
1.0% |
|
| Hepatosplenic T-cell Lymphoma |
26.7% |
| Ventricular Fibrillation |
6.7% |
| Osteoporosis |
5.8% |
| Pancreatitis Acute |
5.0% |
| Pyrexia |
5.0% |
| Superinfection |
5.0% |
| Febrile Bone Marrow Aplasia |
4.2% |
| Hodgkin's Disease |
4.2% |
| Weight Decreased |
4.2% |
| Jaundice |
3.3% |
| Pancreatitis |
3.3% |
| Rash Morbilliform |
3.3% |
| Sepsis |
3.3% |
| Thrombocytopenia |
3.3% |
| Vomiting |
3.3% |
| White Blood Cell Disorder |
3.3% |
| Cerebellar Syndrome |
2.5% |
| Drug Ineffective |
2.5% |
| Hyperbilirubinaemia |
2.5% |
| Premature Baby |
2.5% |
|
| Concomitant |
| Crohn's Disease |
39.1% |
| Product Used For Unknown Indication |
15.7% |
| Drug Use For Unknown Indication |
9.9% |
| Colitis Ulcerative |
6.8% |
| Acute Lymphocytic Leukaemia |
4.2% |
| Prophylaxis |
3.2% |
| Vitamin Supplementation |
2.5% |
| Acute Myeloid Leukaemia |
2.4% |
| Pain |
2.3% |
| Premedication |
2.2% |
| Hypertension |
2.0% |
| Depression |
1.5% |
| Back Pain |
1.2% |
| Nausea |
1.2% |
| Ankylosing Spondylitis |
1.0% |
| Anxiety |
1.0% |
| Blood Pressure |
1.0% |
| Osteoporosis |
1.0% |
| Infection Prophylaxis |
0.9% |
| Rheumatoid Arthritis |
0.9% |
|
| Pyrexia |
11.0% |
| Crohn's Disease |
9.8% |
| Vomiting |
9.8% |
| Thrombocytopenia |
8.5% |
| Weight Decreased |
6.7% |
| Rash |
6.1% |
| Pneumonia |
4.9% |
| Intestinal Obstruction |
4.3% |
| Infusion Related Reaction |
3.7% |
| Toxic Encephalopathy |
3.7% |
| Tuberculosis |
3.7% |
| X-linked Chromosomal Disorder |
3.7% |
| Axonal Neuropathy |
3.0% |
| Injection Site Pain |
3.0% |
| Nephrolithiasis |
3.0% |
| Rectal Cancer |
3.0% |
| Renal Failure Acute |
3.0% |
| Scrotal Abscess |
3.0% |
| Transaminases Increased |
3.0% |
| Urticaria |
3.0% |
|
